| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
1,799 | 1,142 | 108 | 498 | 0 |
| Cost of Revenue
|
-997 | -497 | 0 | -- | 0 |
|
Gross Profit
|
802 | 645 | 108 | 498 | 0 |
| Selling, General and Administrative Expenses
|
-7,909 | -7,768 | -7,334 | -2,835 | -1,980 |
|
Research and Development Expenses
|
-1,783 | -1,482 | -1,954 | -741 | -1,272 |
| Depreciation, Amortization and Depletion
|
-- | -- | -- | -- | 0 |
|
Operating Income/Expenses
|
-9,692 | -9,250 | -9,288 | -3,576 | -3,252 |
|
Total Operating Profit/Loss
|
-8,890 | -8,605 | -9,180 | -3,078 | -3,252 |
| Total Net Finance Income/Expense
|
85 | -70 | -69 | -18 | -574 |
| Net Investment Income
|
-2 | -9,374 | -145 | 37 | 0 |
| Irregular Income/Expenses
|
-251 | -1,604 | -874 | 0 | 30 |
|
Other Income/Expense, Non-Operating
|
-48 | -224 | -190 | 457 | 7 |
|
Non-Operating Income/Expenses, Total
|
-216 | -11,272 | -1,278 | 476 | -537 |
|
Pretax Income
|
-9,106 | -19,877 | -10,458 | -2,602 | -3,789 |
|
Provision for Income Tax
|
-1 | -5 | -2 | -1 | 0 |
|
Earnings from Equity Interest, Post-Tax
|
0 | -- | -- | -- | -- |
|
Net Income from Continuing Operations
|
-9,107 | -19,882 | -10,460 | -2,603 | -3,789 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-9,107 | -19,882 | -10,460 | -2,603 | -3,789 |
|
Net Income after Non-Controlling/Minority Interests
|
-9,107 | -19,882 | -10,460 | -2,603 | -3,789 |
|
Other Adjustments to Net Income Available to Common Stockholders
|
-329 | -4,649 | 0 | -- | -- |
|
Net Income Available to Common Stockholders
|
-9,436 | -24,531 | -10,460 | -2,603 | -3,789 |
|
Diluted Net Income Available to Common Stockholders
|
-9,436 | -24,531 | -10,460 | -2,603 | -3,789 |
| Basic EPS
|
-0.59 | -1.97 | -1.60 | -0.50 | -0.73 |
| Diluted EPS
|
-0.59 | -1.97 | -1.60 | -0.50 | -0.73 |
|
Basic Weighted Average Shares Outstanding
|
15,626.8200 | 12,443.4350 | 6,546.7690 | 5,194.6650 | 5,194.6650 |
|
Diluted Weighted Average Shares Outstanding
|
15,626.8200 | 12,443.4350 | 6,546.7690 | 5,194.6650 | 5,194.6650 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-9,191 | -19,807 | -10,389 | -2,584 | -3,215 |
|
EBITDA
|
-8,989 | -19,635 | -10,322 | -2,584 | -3,201 |
|
Normalized EBITDA
|
-7,449 | -7,881 | -6,571 | -2,289 | -3,171 |
12/31/2022 - 4/6/1994
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade
